Moneycontrol Be a Pro
Get App
SENSEX NIFTY
you are here:

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01026 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Nov 18, 16:00
552.70 -12.10 (-2.14%)
Volume
AVERAGE VOLUME
5-Day
6,998
10-Day
5,190
30-Day
4,137
4,263
  • Prev. Close

    564.80

  • Open Price

    565.00

552.00

Today’s L/H

574.00
482.00

52 Wk L/H

801.20
451.85

L/U Price Band

677.75
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP
    567.32
  • Market Depth (18 Nov 2019)

    BUYSELL
    QTY PRICE PRICE QTY
    90 552.15 557.45 73
    300 552.00 558.45 73
    2 551.00 563.45 73
    78 550.60 566.00 25
    17 550.00 570.00 10
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Nov 18, 15:59
557.65 -7.40 (-1.31%)
Volume
AVERAGE VOLUME
5-Day
124,548
10-Day
114,918
30-Day
117,668
80,677
  • Prev. Close

    565.05

  • Open Price

    565.05

553.10

Today’s L/H

574.25
480.00

52 Wk L/H

799.90
452.05

L/U Price Band

678.05
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    557.65 (1392)

  • VWAP
    566.74
    Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
    Series: EQ
  • DELIVERY AVERAGES
    3-Day
    72.42%
    5-Day
    71.07%
    8-Day
    69.45%
    Deliverables
  • SMA VOLUME
    30
    572.46
    50
    572.07
    150
    547.27
    200
    563.15
    SMA
    572.46

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

Valuation

    • Market Cap (Rs Cr.)
      10,052.91
    • P/E
      18.27
    • Book Value (Rs)
      195.89
    • Dividend (%)
      312.50
    • Market Lot
      1
    • Industry P/E
      28.63
    • EPS (TTM)
      30.53
    • P/C
      15.96
    • Price/Book
      2.82
    • Dividend Yield.(%)
      1.13
    • Face Value (RS)
      2.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      72.42
      5-Day
      71.07
      8-Day
      69.45
      78.09

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      10,052.91
    • P/E
      18.69
    • Book Value (Rs)
      191.93
    • Dividend (%)
      312.50
    • Market Lot
      1
    • Industry P/E
      28.63
    • EPS (TTM)
      29.83
    • P/C
      16.12
    • Price/Book
      2.88
    • Dividend Yield.(%)
      1.13
    • Face Value (RS)
      2.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      72.42
      5-Day
      71.07
      8-Day
      69.45
      78.09

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Simple Moving Averages
DAYS BSE NSE
30 571.81 572.46
50 571.65 572.07
150 546.90 547.27
200 562.87 563.15
Click here to view the Open, High, Low, Close, Volume and Spread data.

Forum

Community Sentiments

  • 100% BUY
  • 0% SELL
  • 0% HOLD
100%
of moneycontrol users recommend buying Natco Pharma

What's your call on Natco Pharma today?

Read 3 investor views

BUY SELL HOLD

Action in Natco Pharma Ltd.

  • Technicals
    JUST NOW

    Natco Pharma closes below 200-Day Moving Average of 563.15 today.

    Nov 18

  • Technicals

    Natco Pharma closes above 200-Day Moving Average of 563.75 today.

    Nov 15

  • Technicals

    Natco Pharma closes above 30-Day,200-Day Moving Average today.

    Oct 22

  • Technicals

    Natco Pharma closes above 30-Day Moving Average of 568.18 today.

    Oct 17

  • Technicals

    Natco Pharma closes above 50-Day Moving Average of 554.02 today.

    Oct 11

  • Technicals

    Natco Pharma closes below 30-Day Moving Average of 563.09 today.

    Oct 04

  • Technicals

    Natco Pharma closes below 200-Day Moving Average of 581.21 today.

    Oct 02

  • Technicals

    Natco Pharma closes below 200-Day Moving Average of 581.21 today.

    Oct 01

  • Technicals

    Natco Pharma closes above 200-Day Moving Average of 584.32 today.

    Sep 24

  • Technicals

    Natco Pharma closes above 150-Day Moving Average of 557.19 today.

    Sep 05

  • AGM/EGM

    Natco Pharma AGM on Sep 05, 2019, Announcement date: Aug 09, 2019

    Sep 04, 11:00

  • Block Deals

    Natco Pharma Block Deal on BSE, Qty: 900,000, Deal Price: 542.00, Value (cr): 48.78, Time: 10:05am

    Sep 03, 10:10

  • Block Deals

    Natco Pharma Block Deal on BSE, Qty: 900,000, Deal Price: 540.00, Value (cr): 48.60, Time: 09:30am

    Aug 30, 09:35

  • Dividend

    Natco Pharma Dividend, Interim Dividend 62.50%, Announcement date: Aug 09, 2019, Record date: Aug 23, 2019, Ex-Div: Aug 22, 2019

    Aug 21, 11:00

  • Views

    Hold Natco Pharma; target of Rs 595: ICICI Direct

    Aug 13, 13:15

  • Technicals

    Natco Pharma closes above 50-Day Moving Average of 527.52 today.

    Aug 05

  • News

    Natco Pharma gets EIR from USFDA for Kothur facility

    Aug 05, 13:45

  • Technicals

    Natco Pharma closes above 30-Day,50-Day Moving Average today.

    Aug 02

  • Technicals

    Natco Pharma closes below 50-Day Moving Average of 531.97 today.

    Jul 11

  • Technicals

    Natco Pharma closes below 30-Day,50-Day Moving Average today.

    Jul 10

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Nov 18, 09:15
565.00 0.20 (0.04%)
High 565.00
Low 565.00
Prev. Close 564.80

NSE

Nov 18, 09:15
565.05 0.00 (0.00%)
High 565.30
Low 565.05
Prev. Close 565.05

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 457.70 464.70 416.30 531.90 522.40
Other Income 33.90 20.40 30.70 23.70 39.70
PBDIT 137.00 195.70 150.20 210.40 230.80
Net Profit 122.20 147.70 123.40 162.00 193.10
  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 485.70 492.30 455.70 556.70 543.50
Other Income 33.20 21.00 31.00 23.30 40.00
PBDIT 134.30 191.30 148.30 208.40 220.50
Net Profit 117.70 142.80 120.40 159.30 181.60

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 36.50 36.90
Networth 3,563.20 3,125.40
Total Debt 384.50 173.00
Net Block 1,214.90 1,015.30
Investments 244.40 149.60
Total Assets 3,947.70 3,298.40

Historical Prices

On
Current Price %Gain / Loss
Open Price 721.00 565.00
-21.64
High Price 742.40 574.00
-22.68
Low Price 721.00 552.00
-23.44
Close Price 735.05 564.80
-23.16
Volume 12,842 4,263
-66.8
On
Current Price %Gain / Loss
Open Price 728.80 565.05
-22.47
High Price 742.60 574.25
-22.67
Low Price 723.10 553.10
-23.51
Close Price 733.50 565.05
-22.97
Volume 201,013 80,677
-59.86
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11884.50 -11.00 -0.09
SENSEX 40284.19 -72.50 -0.18
NIFTY BANK 30992.10 -16.30 -0.05
NIFTY IT 15295.30 -15.30 -0.10
S&P BSE Smallcap 13362.61 36.21 0.27
Index Price Change %Chg
DAX (Nov 18) 13,165.32 -76.43 -0.58
CAC (Nov 18) 5,909.47 -29.80 -0.50
FTSE (Nov 18) 7,297.00 -5.94 -0.08
Nasdaq (Nov 18) 8,529.37 -11.46 -0.13
SGX Nifty (Nov 18) 11,916.00 -7.00 -0.06

CORPORATE ACTION

Date Agenda
Nov 12, 2019 Quarterly Results & Interim Dividend
Aug 09, 2019 Quarterly Results & Interim Dividend
May 27, 2019 Audited Results & Interim Dividend
Feb 12, 2019 Quarterly Results & Interim Dividend
Type Dividend% Ex-Dividend date
Interim 50.00 Nov 21, 2019
Interim 62.50 Aug 22, 2019
Interim 62.50 Jun 06, 2019
Interim 175.00 Feb 21, 2019
Interim 75.00 Aug 20, 2018
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Natco Pharma
Old FV New FV Ex-Split
10 2 Nov 26, 2015
Ratio Premium Ex-Bonus
No Rights Information is available for Natco Pharma
Date Agenda
Sep 05, 2019 -
Sep 15, 2018 -
Sep 28, 2017 (Revised)
Sep 30, 2016 -
Nov 30, 2015 -

Dividend Summary

For the year ending March 2019 Natco Pharma has declared an equity dividend of 312.50% amounting to Rs 6.25 per share. At the current share price of Rs 557.65 this results in a dividend yield of 1.12%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 March 2019 December 2018 September 2018
Promoters 49.01 48.71 48.42 48.34
Pledged 0 0 0 0
FII/FPI 20.1 21.39 23.82 24.32
Total DII 12.83 11.45 10.02 10.15
Fin.Insts 1.04 0.99 0.7 0.72
Insurance Co 0 0 0 0
MF 6.84 5.89 5.13 5.13
Others DIIs 4.95 4.57 4.19 4.3
Others 18.05 18.45 17.74 17.19
Total 99.99 100 100 100

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Natco Pharma 552.70 -2.14 801.20 482.00 10052.91 1,986.30 667.10
Sun Pharma 424.35 2.28 616.50 350.40 101815.78 10,303.21 816.60
Divis Labs 1731.60 -0.94 1773.00 1214.25 45968.54 4,879.66 1,332.65
Dr Reddys Labs 2736.05 0.21 2965.20 2065.30 45458.31 10,625.50 1,277.30
Cipla 459.75 -0.72 645.00 389.55 37060.76 12,374.01 1,888.41

COMPANY OVERVIEW

Piramal Enterprises Ltd is one of the largest pharmaceutical companies in India.The company operates two divisions namely healthcare solutions and pharma solutions.The products and services offered by the company includes Pharma Solutions- This division is engaged in manufacturing of API and formulations in nine therapeutic areas. The company operates one of the leading custom manufacturing businesses in the world, due to this PHL offers a full lifecycle partnership to small/virtual and big pharma. They provide services such as clinical phase APIs, clinical phase formulations and commercial APIs. They also offer packaging solutions.Healthcare solutions- Under this, PHL has developed multi-ingredient formulations and single-ingredients products.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Venture Capital & Corporate Investments Pvt. Ltd.

    • Address

      Bharat Nagar

    • City

      Hyderabad 500018

    • State

      Telangana

    • Tel. No.

      040-23818475, 23818476, 23868023

    • Fax No.

      040-23868024

    • Email

      info@vccilindia.com

    • Internet

      http://www.vccilindia.com

  • Management

    • Name

      Designation

    • V C Nannapaneni

      Chairman & Managing Director

    • Rajeev Nannapaneni

      Vice Chairman & CEO

    • T V Rao

      Independent Director

    • G S Murthy

      Independent Director

    • D G Prasad

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      Yes

    • S&P CNX 500

      Yes

    • CNX Midcap

      No

About Natco Pharma Ltd.

Natco Pharma is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.

Related Searches